Cambridge Cognition wins new digital health contract worth over £700,000

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that it has won a new contract with a major pharmaceutical client to provide digital assessments of mood and cognition for a depression trial. The contract is worth over £700,000 with most of the revenue expected to be recognised in 2021.

Impairments in cognition can persist after recovery from a period of depression and this can contribute to difficulties in reaching a full recovery. So, in efforts to thoroughly assess treatment efficacy, Cambridge Cognition has been contracted to deploy remote assessments of mood and cognition over a 12-month period. The assessments will be delivered on patients’ mobile phones with their performance and wellbeing monitored by the pharmaceutical client. 

The inclusion of remote and brief assessments during both the core and extension periods of the trial will provide the client with a better understanding of the relationships between mood, cognition and recovery. Cambridge Cognition is in a unique position to support the delivery of this trial with expertise in both gold-standard cognitive assessment and innovative digital health solutions for frequent, remote testing.

Matthew Stork, Chief Executive Officer of Cambridge Cognition, said:

“We are excited to be working with another pharmaceutical company that recognises the importance of frequent objective cognitive assessments in the development of treatments for central nervous system disorders. This new contract further validates the Company’s strategy as again we will be configuring existing digital health solutions rather than undertaking bespoke software development. It also further highlights the opportunity available to Cambridge Cognition to provide remote, patient-centred solutions in the CNS market.”

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Cambridge Cognition Holdings

More articles like this

Cambridge Cognition Holdings

Cambridge Cognition forms new Scientific Advisory Board

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, is pleased to announce the formation of a Scientific Advisory Board. This expert board will provide scientific guidance and valuable market insights, primarily focusing

Cambridge Cognition Holdings

Cambridge Cognition Holdings Changes its Auditor to Crowe UK LL

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Board has approved the appointment of Crowe UK LLP as the Group’s new external auditor following a competitive

Cambridge Cognition Holdings

Cambridge Cognition strengthens balance sheet with £3 million loan

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the Company has obtained a £3.0 million loan from Claret European Specialty Lending Company III, S.à r.l.  Claret specialises in

Cambridge Cognition Holdings

Cambridge Cognition Holdings Revision to Explanatory Note

Cambridge Cognition (LON:COG), which develops and markets digital solutions to assess brain health, has announced that the explanatory note to Resolution 7 in the Notice of the Annual General Meeting (“AGM”) to be held on 28 June 2023

Cambridge Cognition Holdings

Cambridge Cognition publishes Annual Report and Accounts

Cambridge Cognition Holdings plc (LON:COG), which develops and markets digital solutions to assess brain health, has confirmed that the Annual Report and Accounts for the year ended 31 December 2022 and the Notice of the Annual General

Cambridge Cognition Holdings

Cambridge Cognition growth strategy clearly paying off (VIDEO)

Cambridge Cognition Holdings plc (LON:COG) CEO Matthew Stork joins DirectorsTalk Interviews to discuss prelim results for the year ended 31 December 2022. In this interview Matthew talks us through the result highlights, explains how the the acquisitions